Electronic health record evidence suggests undercoding, underrecognition, and low antifibrotic use in progressive pulmonary fibrosis
Bradley A Sheffield, Brian J Cassel, Apostolos Perelas, Patricia Sime, Peter Jackson · 2026
Read Electronic health record evidence suggests undercoding, underrecognition, and low antifibrotic use in progressive pulmonary fibrosis by Bradley A Sheffield, Brian J Cassel, Apostolos Perelas, Patricia Sime, Peter Jackson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351328.txt.
Description
Bradley A Sheffield and co-authors mine a huge United States health record network for patients with progressive lung scarring who never receive the diagnosis code. The condition worsens steadily and anti-scarring drugs can slow it, yet coded prevalence looked far below earlier estimates. The team built three proxy definitions of increasing strictness from related lung diagnoses plus signs of progression, then compared coded and proxy patients on treatment and outcomes.
Coded cases were rare, while even the strictest proxy found many times more likely patients. Anti-scarring drug use was low everywhere, but far lower in proxy groups than in coded patients, who still went untreated most of the time. Sheffield and colleagues argue many Americans with this disease sit unrecognized and untreated inside ordinary records.
Catalog record
| CREATOR | Bradley A Sheffield, Brian J Cassel, Apostolos Perelas, Patricia Sime, Peter Jackson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15274 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |